| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2014 | Apr 17, 2014 | Akari Therapeutics Plc | 10% Owner | Buy | 87.5 | +20,100 | 2.65% | ✗ | $101.1K |
| Apr 9, 2014 | Apr 11, 2014 | Akari Therapeutics Plc | 10% Owner | Buy | 61.3 | +2,575 | 0.34% | ✗ | $13.8K |
| Apr 4, 2014 | Apr 8, 2014 | Akari Therapeutics Plc | 10% Owner | Buy | 92.5 | +68,404 | 9.96% | ✗ | $382.5K |
| Mar 31, 2014 | Apr 2, 2014 | Akari Therapeutics Plc | 10% Owner | Buy | 82.5 | +28,207 | 1.41% | ✗ | $175.5K |
| Mar 25, 2014 | Mar 27, 2014 | Akari Therapeutics Plc | 10% Owner | Buy | 87.5 | +16,203 | 2.52% | ✗ | $107.9K |
| Mar 20, 2014 | Mar 24, 2014 | Akari Therapeutics Plc | 10% Owner | Buy | 82.5 | +11,100 | 1.76% | ✗ | $75.8K |
| Aug 18, 2010 | Aug 20, 2010 | SOLIGENIX, INC. | 10% Owner | Sell | 22.5 | -352,314 | -1.61% | ✗ | $84.6K |